Clinical trials
Completed Observational Endocarditis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 29 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Central Hospital, Nancy, France | 3 |
| Centre Hospitalier Universitaire de Besancon | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Assiut University | 1 |
| Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria | 1 |
| Centre Chirurgical Marie Lannelongue | 1 |
| Centre Hospitalier Annecy Genevois | 1 |
| Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec | 1 |
| Clinique Pasteur | 1 |
| Daniel Benjamin | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endocarditis | 29 |
| Bacteremia | 3 |
| Heart Valve Diseases | 3 |
| Sepsis | 2 |
| Staphylococcal Infections | 2 |
| Acute Kidney Injury | 1 |
| Acute-Phase Reaction | 1 |
| Adenoviridae Infections | 1 |
| Anxiety Disorders | 1 |
| Aortic Aneurysm | 1 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.